Covid-19样品收集套件市场份额，规模，趋势，行业分析报告，由产品（拭子，病毒传输媒体，血液收集套件，其他）;通过申请（诊断，研究）;由收集网站（医院和诊所，家庭测试），按地区;分部预测，2021 - 2028
- 发布日期：2月2021年
- 第111页：111
- Format: PDF
- 报告ID：PM1806
- Base Year: 2020
- Historical Data: 2020
Report Summary
The global COVID-19 sample collection kits market was valued at USD 12.83 billion in 2020 and is expected to grow at a CAGR of 2.3% during the forecast period. The recent surge in COVID-19 cases and a worldwide necessity for collecting samples of COVID-19 strains are the prominent factors attributing to the COVID-19 sample collection kits market growth.
收集样品是Covid-19菌株的有效诊断中最重要的和关键步骤，因为假标本收集可能导致误导性测试结果。符合此目的，CDC和其他有关医疗组织引入了收集样本并简化Covid-19相关服务的价值yabo娱乐vip链的标准协议。
在持续的大流行期间，通过全球锁定到位，涉及拭子和病毒样本收集套件的公司已经扩大了他们的生产，以满足需求的指数增加。
例如，在5月2020年5月，基于印度的个人卫生公司“Suparshva拭子”宣布扩大其生产的聚酯拭子生产，用于采集Covid-19试验从2到500万次采集。根据公司的索赔，它拥有全年棉花芽最多的棉花芽，可以在一周内将棉签生产飙升至超过3000万。聚酯拭子将花费每单位或更少的3个或更小于进口拭子。
Know more about this report:请求样本页面
行业动态
成长司机
Covid-19样品收集套件市场的主要利益相关者与区域制造商和供应商合作，加速了全球Covid-19样品套件市场中的拭子和病毒传输媒体的供应。随着持续的大流行和需求激增，全球的公司专注于最大化市场的产出和供应的战略举措。
In this direction, in November 2020, the University of South Florida (USF) has introduced a 3D printed nasal swab for commercial use. The organization has produced more than 100,000+ products, and hospitals across the world have used 3D files to develop millions of swabs for use in PoC testing.
Covid-19样品收集套件市场报告范围
The market is primarily segmented on the basis of product, application, end-use, and geographic region.
By Product |
By Application |
By Collection Site |
By Region |
|
|
|
|
Know more about this report:请求样本页面
Insight by Application
In 2020, the diagnostics market segment accounted for the largest share in the global market for COVID-19 sample collection kits. Such a high share is due to approvals for diagnostic tests by FDA for the COVID-19. It is being estimated that, by December 2020, there were 1,295 tests were approved by FDA under emergency use authorization. It included 227 molecular tests, 61 antibody tests, and 7 antigen tests for the diagnosis of COVID-19 infections.
然而，研究市场部分预计将在预测期内见证利润丰厚的市场增长。这种市场增长是由于研发计划的兴起，部署了样品收集套件，以证明各种诊断测试的有效性。此外，对Covid-19发病机制的广泛研究进一步提高了市场部门的增长前景。
收集网站的洞察
2020年,医院和诊所段帐户ed for the largest revenue share for these sample collection kits. The exponential rise in hospitalization due to COVID-19 is primarily responsible for such market growth. As there is a global rise in COVID-19 cases, most hospitals are expanding their capabilities for the diagnosis of COVID-19. This has directly resulted in increased sample collection in the hospital settings through kits.
由于Covid-19病毒和全国范围内的锁定的高感染率，预计，家庭测试市场分部将在预测期内见证有利可图的增长率。最近，在2020年11月，MyBiopassport介绍了“Covid-19和免疫概况”测试。它是一种家庭血液样本收集测试。这将有助于个人确定他是否被感染了Covid-19。
地理概述
Geographically, the global market for COVID-19 sample collection kits is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). In North America, the U.S. is the most highly affected country with the highest number of active cases.
It is being reported that, as of December 7, 2020, U.S. had performed more than 207 million COVID-19 tests through kits, which is the highest among all the countries, followed by the European market. In November 2020, the UK government planned to ramp up testing capacity by establishing new labs across the nation, by early next year. These facilities would likely process 600,000 PCR tests in a day through these kits.
Competitive Insight
The global market for COVID-19 sample collection kits is flooded with small- and large-scale players. Some of the key players operating in the market for COVID-19 sample collection kits are Lucence Diagnostics Pte Ltd., Laboratory Corporation of America Holdings, Trinity Biotech, Puritan Medical Products, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., COPAN Diagnostics, Hardy Diagnostics, Quidel Corporation, Quest Diagnostics, Vitagene Inc., HiMedia Laboratories, and VIRCELL S.L.
